Delivery Order SPE2DB22D1202-SPE2DB25FUZK7

Award Date 5/6/25
Potential Completion Date 5/7/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,470.43 firm fixed-price delivery order is for the supply of EMERPHED 50 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EMERPHED 50 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $8,902.08 and a period of performance through May 8, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,895.28, is a Delivery Order for the supply of EMERPHED 25 MG/5 ML SYRINGE 5ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and a completion date of November 27, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) worth...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML. The contract is a Delivery Order with a Firm Fixed Price, valued at $2,834.82, and has an ultimate completion date of January 17, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract is associated with a larger Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide EMERPHED 25 MG/5 ML SYRINGE 5ML. The $4,766.15 firm fixed-price delivery order has a completion date of May 9, 2023 and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to supply a wide range of pharmaceutical products and...
This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), awarded to Amerisourcebergen Drug Corp. for the supply of 4565786556 - EMERPHED 50 MG/10 ML SYRINGE 10ML. The award has a ceiling value of $2,296.21 and a completion date of September 13, 2024. This contract is for the delivery of essential pharmaceutical products to support military treatment facilities and programs. Amerisourcebergen is a major supplier of medical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,855.36, is a delivery order with a firm fixed-price pricing type and an ultimate completion date of March 18, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $958,910.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price pricing type and a performance period extending through May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,736.21 firm fixed-price delivery order contract is for the provision of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract has no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,161.68 firm-fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract has an ultimate...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUZK7
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,114.73 firm fixed-price delivery order is for the medication EMERPHED 50 MG/10 ML VIAL 10ML, with a performance period through May 7, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The delivery order in this specific award is not designated as a set-aside.

Generated 8/10/25, 1:02 AM